Literature DB >> 12479862

Glypicans.

Lars-Ake Fransson1.   

Abstract

A family of lipid-linked heparan sulfate (HS) proteoglycans, later named glypicans, were identified some 15 years ago. The discoveries that mutations in genes involved in glypican assembly cause developmental defects have brought them into focus. Glypicans have a characteristic pattern of 14 conserved cysteine residues. There are also two-three attachment sites for HS side-chains near the membrane anchor. The HS side-chains consist of a repeating disaccharide back-bone that is regionally and variably modified by epimerization and different types of sulfations, creating a variety of binding sites for polycationic molecules, especially growth factors. Recycling forms of glypican-1 are potential vehicles for transport of cargo into and through cells. The glypican-1 core protein is S-nitrosylated and nitric oxide released from these sites cleave the HS chains at glucosamine units lacking N-substitution. This processing is necessary for polyamine uptake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479862     DOI: 10.1016/s1357-2725(02)00095-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  34 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  MicroRNA-125a inhibits cell growth by targeting glypican-4.

Authors:  Chao Feng; Jie Li; Jinlan Ruan; Kan Ding
Journal:  Glycoconj J       Date:  2012-05-27       Impact factor: 2.916

3.  Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.

Authors:  Paul O'Callaghan; Elina Sandwall; Jin-Ping Li; Hong Yu; Rivka Ravid; Zhi-Zhong Guan; Toin H van Kuppevelt; Lars N G Nilsson; Martin Ingelsson; Bradley T Hyman; Hannu Kalimo; Ulf Lindahl; Lars Lannfelt; Xiao Zhang
Journal:  Brain Pathol       Date:  2008-04-11       Impact factor: 6.508

4.  Craniofacial skeletal defects of adult zebrafish Glypican 4 (knypek) mutants.

Authors:  Elizabeth E LeClair; Stephanie R Mui; Angela Huang; Jolanta M Topczewska; Jacek Topczewski
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

Review 5.  Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Authors:  Paul C Billings; Maurizio Pacifici
Journal:  Connect Tissue Res       Date:  2015       Impact factor: 3.417

6.  Circulating Biomarkers of Testosterone's Anabolic Effects on Fat-Free Mass.

Authors:  Grace Huang; Guilherme V Rocha; Karol M Pencina; Karen Cox; Venkatesh Krishnan; Kim Henriksen; Peter Mitchell; Sean E Sissons; Zhuoying Li; Anders F Nedergaard; Morten A Karsdal; Shu Sun; Thomas W Storer; Shehzad Basaria; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2019-05-23       Impact factor: 5.958

7.  The developmentally-regulated Smoc2 gene is repressed by Aryl-hydrocarbon receptor (Ahr) signaling.

Authors:  Peijun Liu; Dorothy E Pazin; Rebeka R Merson; Kenneth H Albrecht; Cyrus Vaziri
Journal:  Gene       Date:  2008-12-24       Impact factor: 3.688

8.  MicroRNA-1291-mediated silencing of IRE1α enhances Glypican-3 expression.

Authors:  Marion Maurel; Nicolas Dejeans; Saïd Taouji; Eric Chevet; Christophe F Grosset
Journal:  RNA       Date:  2013-04-18       Impact factor: 4.942

9.  Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.

Authors:  Bowen Liu; Shirish Paranjpe; William C Bowen; Aaron W Bell; Jian-Hua Luo; Yan-Ping Yu; Wendy M Mars; George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

10.  The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

Authors:  Bodil Fadnes; Oystein Rekdal; Lars Uhlin-Hansen
Journal:  BMC Cancer       Date:  2009-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.